Allurion Technologies (ALURD) Invested Capital (2022 - 2024)

Allurion Technologies' (ALURD) quarterly Invested Capital came in at $39.0 million in Q1 2024, up 0.81% on a QoQ basis from $38.6 million in Q4 2023.

Allurion Technologies (ALURD) Invested Capital (2022 - 2024) Analysis & Trends

Allurion Technologies (ALURD) has 3 years of Invested Capital data on file, last reported at $39.0 million in Q1 2024.

Quarterly Invested Capital changed N/A year-over-year to $39.0 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $39.0 million (down 74.03% YoY) and the FY2023 annual result came in at $38.6 million, down 27.58% from the prior year.
Invested Capital rose to $39.0 million in Q1 2024, from $38.6 million in the prior quarter.
In the past five years, Invested Capital ranged from a high of $57.7 million in Q3 2023 to a low of $38.6 million in Q4 2023.
A 3-year average of $48.5 million and a median of $53.4 million in 2022 frame the typical range for Invested Capital.
The widest YoY moves for Invested Capital: up 27.58% in 2023, down 27.58% in 2023.
Tracing ALURD's Invested Capital over 3 years: stood at $53.4 million in 2022, then retreated by 27.58% to $38.6 million in 2023, then climbed by 0.81% to $39.0 million in 2024.
The last three Invested Capital figures came in at $39.0 million (Q1 2024), $38.6 million (Q4 2023), and $57.7 million (Q3 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	199.44 Bn	193.84 Bn	7.27 Bn	3.01 Bn
2	Stryker	127.32 Bn	123.85 Bn	4.50 Bn	750.00 Mn
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn	1.71 Bn
5	Edwards Lifesciences	51.90 Bn	47.65 Bn	1.35 Bn	-
6	Dexcom	34.30 Bn	32.36 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.74 Bn	31.63 Bn	2.18 Bn	2.00 Mn
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn	1.34 Bn
9	Steris	23.05 Bn	22.56 Bn	684.20 Mn	243.40 Mn
10	Allurion Technologies	49.18 Mn	44.13 Mn	1.23 Mn	-

Download Data